STOCK TITAN

Bio-Rad Laboratories Inc. - BIO STOCK NEWS

Welcome to our dedicated news page for Bio-Rad Laboratories (Ticker: BIO), a resource for investors and traders seeking the latest updates and insights on Bio-Rad Laboratories.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bio-Rad Laboratories's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bio-Rad Laboratories's position in the market.

Rhea-AI Summary
Bio-Rad Laboratories, Inc. to participate in Citi's 2024 Unplugged Medtech and Life Sciences Access Day fireside chat event. The event will take place on February 29, 2024, at 2:30 PM Eastern Time. Investors can access the live webcast and replay on Bio-Rad's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.14%
Tags
conferences
-
Rhea-AI Summary
Bio-Rad Laboratories, Inc. reported fourth-quarter 2023 net sales of $681.2 million, a 6.7% decrease from the previous year. Life Science segment sales declined by 19.1%, while Clinical Diagnostics segment sales increased by 5.3%. The company's net income for Q4 2023 was $349.7 million. Full-year 2023 net sales decreased by 4.7% to $2,671.3 million. Bio-Rad introduced various products and entered partnerships in 2023. The company expects a 1.0 to 2.5% revenue growth for 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.59%
Tags
earnings
-
Rhea-AI Summary
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) will release its financial results for Q4 and full year 2023 on February 15, 2024. The management will discuss the results in a conference call on the same day. Investors can access the call via phone or live webcast. A replay will be available for up to a year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.08%
Tags
conferences earnings
Rhea-AI Summary
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to host one-on-one meetings with investors at the 42nd Annual J.P. Morgan Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.78%
Tags
conferences
-
Rhea-AI Summary
Bio-Rad Laboratories, Inc. reports financial results for Q3 2023. Total net sales decreased by 7.1% compared to the same period last year. Life Science segment net sales decreased by 17.1%, while Clinical Diagnostics segment net sales increased by 1.7%. Gross margin was 53.1%. Net income for Q3 2023 was $106.3 million compared to a net loss of $162.8 million in Q3 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.15%
Tags
earnings
-
Rhea-AI Summary
Bio-Rad Laboratories to report Q3 2023 financial results on October 26, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
conferences earnings
Rhea-AI Summary
Bio-Rad Laboratories to participate in fireside chat event at Wells Fargo's Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.65%
Tags
conferences
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.01%
Tags
buyback
Rhea-AI Summary
Bio-Rad Laboratories, Inc. will report its financial results for Q2 2023 on August 3, 2023. A conference call will be held to discuss the results. A live webcast will also be available on the company's website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.47%
Tags
conferences earnings
Bio-Rad Laboratories Inc.

NYSE:BIO

BIO Rankings

BIO Stock Data

9.40B
19.96M
15.23%
81.35%
1.81%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
US
Hercules

About BIO

bio-rad laboratories (nyse: bio and biob) offers a broad range of innovative tools and services to the life science research and clinical diagnostics markets. founded in 1952, bio-rad has a global team of more than 7,600 employees and serves more than 100,000 research and industry customers worldwide through the company's global network of operations. throughout its existence, bio-rad has built strong customer relationships that advance scientific research and development efforts and support the introduction of new technology used in the growing fields of genomics, proteomics, drug discovery, food safety, medical diagnostics, and more. based in hercules, ca, bio-rad has operations worldwide.